相似文献
1
It is time to look at heart failure with preserved ejection fraction from the right side.
Circulation. 2014 Dec 23;130(25):2272-7. doi: 10.1161/CIRCULATIONAHA.114.013536. Epub 2014 Nov 12.
2
Letter by Guazzi regarding article, "right ventricular function in heart failure with preserved ejection fraction: a community-based study".
Circulation. 2015 Sep 29;132(13):e160. doi: 10.1161/CIRCULATIONAHA.114.014332.
3
Response to letter regarding article, "right ventricular function in heart failure with preserved ejection fraction: a community-based study".
Circulation. 2015 Sep 29;132(13):e161. doi: 10.1161/CIRCULATIONAHA.115.016481.
4
Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
Circulation. 2014 Dec 23;130(25):2310-20. doi: 10.1161/CIRCULATIONAHA.113.008461. Epub 2014 Nov 12.
5
Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dysfunction and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles.
Am J Cardiol. 2009 Aug 1;104(3):414-8. doi: 10.1016/j.amjcard.2009.03.057. Epub 2009 Jun 6.
6
Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
Eur J Heart Fail. 2017 Dec;19(12):1664-1671. doi: 10.1002/ejhf.873. Epub 2017 Jun 8.
7
Tricuspid regurgitation duration correlates with cardiovascular magnetic resonance-derived right ventricular ejection fraction and predict prognosis in patients with pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2014 Jan;15(1):18-23. doi: 10.1093/ehjci/jet094. Epub 2013 May 22.
8
Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction.
Eur J Heart Fail. 2017 Jul;19(7):873-879. doi: 10.1002/ejhf.664. Epub 2016 Nov 17.
9
Differential right ventricular regional function and the effect of pulmonary hypertension: three-dimensional echo study.
Heart. 2011 Jun;97(12):1004-11. doi: 10.1136/hrt.2010.208900. Epub 2011 Apr 12.
10
Echocardiographic assessment of right ventricular function: how to account for tricuspid regurgitation and pulmonary hypertension.
JACC Cardiovasc Imaging. 2012 Jul;5(7):747-53. doi: 10.1016/j.jcmg.2011.08.026.
引用本文的文献
1
Prognostic significance of right ventricular dysfunction in heart failure with preserved ejection fraction: a meta-analysis of reconstructed time-to-event data.
Echo Res Pract. 2025 May 29;12(1):13. doi: 10.1186/s44156-025-00080-5.
2
Targeting estrogen receptor signaling for treating heart failure.
Heart Fail Rev. 2024 Jan;29(1):125-131. doi: 10.1007/s10741-023-10356-9. Epub 2023 Oct 3.
3
Sex differences and related estrogenic effects in heart failure with preserved ejection fraction.
Heart Fail Rev. 2023 Jul;28(4):937-948. doi: 10.1007/s10741-022-10274-2. Epub 2022 Oct 3.
4
Functional and Metabolic Imaging in Heart Failure with Preserved Ejection Fraction: Promises, Challenges, and Clinical Utility.
Cardiovasc Drugs Ther. 2023 Apr;37(2):379-399. doi: 10.1007/s10557-022-07355-7. Epub 2022 Jul 26.
5
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension.
Heart Fail Rev. 2023 May;28(3):745-755. doi: 10.1007/s10741-021-10208-4. Epub 2022 Jan 31.
6
Correlation Between Liver Stiffness and Diastolic Function, Left Ventricular Hypertrophy, and Right Cardiac Function in Patients With Ejection Fraction Preserved Heart Failure.
Front Cardiovasc Med. 2021 Nov 25;8:748173. doi: 10.3389/fcvm.2021.748173. eCollection 2021.
7
Right Ventricular Dysfunction Staging System for Mortality Risk Stratification in Heart Failure With Preserved Ejection Fraction.
J Clin Med. 2020 Mar 18;9(3):831. doi: 10.3390/jcm9030831.
8
Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension.
Pulm Circ. 2019 Dec 18;9(4):2045894019878599. doi: 10.1177/2045894019895452. eCollection 2019 Oct-Dec.
9
Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction.
Eur Heart J. 2019 Feb 21;40(8):689-697. doi: 10.1093/eurheartj/ehy809.
10
High-sensitivity C-reactive protein in heart failure with preserved ejection fraction.
PLoS One. 2018 Aug 16;13(8):e0201836. doi: 10.1371/journal.pone.0201836. eCollection 2018.
本文引用的文献
1
Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
Circulation. 2014 Dec 23;130(25):2310-20. doi: 10.1161/CIRCULATIONAHA.113.008461. Epub 2014 Nov 12.
2
Optimal pacing for right ventricular and biventricular devices: minimizing, maximizing, and right ventricular/left ventricular site considerations.
Circ Arrhythm Electrophysiol. 2014 Oct;7(5):968-77. doi: 10.1161/CIRCEP.114.001360.
3
Traditional and innovative echocardiographic parameters for the analysis of right ventricular performance in comparison with cardiac magnetic resonance.
Eur Heart J Cardiovasc Imaging. 2015 Jan;16(1):47-52. doi: 10.1093/ehjci/jeu156. Epub 2014 Sep 3.
4
Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.
Circ Heart Fail. 2014 Sep;7(5):740-51. doi: 10.1161/CIRCHEARTFAILURE.114.001583. Epub 2014 Aug 13.
5
New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.
Eur Heart J. 2014 Oct 21;35(40):2797-815. doi: 10.1093/eurheartj/ehu204. Epub 2014 Aug 7.
6
The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure.
Circ Res. 2014 Jun 20;115(1):176-88. doi: 10.1161/CIRCRESAHA.113.301129.
7
Right heart dysfunction in heart failure with preserved ejection fraction.
Eur Heart J. 2014 Dec 21;35(48):3452-62. doi: 10.1093/eurheartj/ehu193. Epub 2014 May 29.
8
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.
Circ Heart Fail. 2014 Mar 1;7(2):288-99. doi: 10.1161/CIRCHEARTFAILURE.113.000854. Epub 2013 Dec 23.
9
Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.
J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D22-33. doi: 10.1016/j.jacc.2013.10.027.
10
Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases.
Circulation. 2013 Sep 24;128(13):1470-9. doi: 10.1161/CIRCULATIONAHA.112.000667.
Zotero 插件